Home
XNCR
XNCR News

Latest Xencor Inc. (XNCR) News on January 22, 2025

After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR)

Zacks

2 days ago

After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR)

Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks

Zacks

7 days ago

Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks

Argus Research

7 days ago

XNCR: Lowering target price to $20.00

Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know

Zacks

8 days ago

Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know

Argus Research

a month ago

XNCR: What does Argus have to say about XNCR?

Argus Research

a month ago

XNCR: Rating increased to a HOLD

All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy

Zacks

a month ago

All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy

MT Newswires

a month ago

Wells Fargo Initiates Xencor at Overweight With $37 Price Target

Argus Research

a month ago

XNCR: Lowering target price to $23.00

Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet

Zacks

2 months ago

Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet

Argus Research

2 months ago

XNCR: Raising target price to $24.00

MT Newswires

2 months ago

Piper Sandler Upgrades Xencor to Overweight, Price Target is $30

Argus Research

2 months ago

XNCR: Raising target price to $23.00

Xencor to Participate at Upcoming Investor Conferences

Business Wire

2 months ago

Xencor to Participate at Upcoming Investor Conferences

MT Newswires

2 months ago

Top Premarket Gainers

Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade

Zacks

2 months ago

Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade

Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross

Zacks

2 months ago

Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross

MT Newswires

2 months ago

Xencor Insider Sold Shares Worth $1,612,639, According to a Recent SEC Filing

Argus Research

2 months ago

XNCR: Raising target price to $25.00

Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Simply Wall St.

2 months ago

Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14%

Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates

Zacks

3 months ago

Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Xencor: Q3 Earnings Snapshot

Xencor Reports Third Quarter 2024 Financial Results

Business Wire

3 months ago

Xencor Reports Third Quarter 2024 Financial Results

Argus Research

3 months ago

XNCR: What does Argus have to say about XNCR?

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease

Business Wire

3 months ago

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease

Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect?

Zacks

3 months ago

Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect?

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

Zacks

3 months ago

Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?

Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy?

State Street Corp's Strategic Reduction in Xencor Inc Holdings

GuruFocus.com

3 months ago

State Street Corp's Strategic Reduction in Xencor Inc Holdings

Wall Street Analysts Predict a 67.2% Upside in Xencor (XNCR): Here's What You Should Know

Zacks

3 months ago

Wall Street Analysts Predict a 67.2% Upside in Xencor (XNCR): Here's What You Should Know

Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases

Business Wire

3 months ago

Xencor Presents Preclinical Data on XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, to be Developed for Patients with Inflammatory Bowel Diseases

Argus Research

3 months ago

XNCR: What does Argus have to say about XNCR?

Xencor Announces Upcoming Change to Board of Directors

Business Wire

4 months ago

Xencor Announces Upcoming Change to Board of Directors

MT Newswires

4 months ago

RBC Raises Price Target on Xencor to $34 From $31, Keeps Outperform, Speculative Risk

MT Newswires

4 months ago

Xencor Raises $201.3 Million From Public Offering

Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Business Wire

4 months ago

Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains?

Zacks

4 months ago

Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains?

MT Newswires

4 months ago

Xencor Prices $175 Million Public Stock Offering

Xencor Announces Pricing of $175 Million Public Offering of Common Stock

Business Wire

4 months ago

Xencor Announces Pricing of $175 Million Public Offering of Common Stock

MT Newswires

4 months ago

Xencor Launching Stock Sale; Shares Lower After-Hours

Xencor Announces Proposed Public Offering of Common Stock

Business Wire

4 months ago

Xencor Announces Proposed Public Offering of Common Stock

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

Zacks

4 months ago

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

MT Newswires

4 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Monday Afternoon

MT Newswires

4 months ago

Xencor Shares Rise After 4 New Drug Candidates for Autoimmune, Inflammatory Diseases Announced

Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs

Business Wire

4 months ago

Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs

Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024

Business Wire

5 months ago

Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024

Argus Research

5 months ago

XNCR: What does Argus have to say about XNCR?

Argus Research

5 months ago

XNCR: Raising target price to $18.00

Estimating The Intrinsic Value Of Xencor, Inc. (NASDAQ:XNCR)

Simply Wall St.

5 months ago

Estimating The Intrinsic Value Of Xencor, Inc. (NASDAQ:XNCR)

Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates

Zacks

6 months ago

Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates

Associated Press Finance

6 months ago

Xencor: Q2 Earnings Snapshot

Xencor Reports Second Quarter 2024 Financial Results

Business Wire

6 months ago

Xencor Reports Second Quarter 2024 Financial Results

Argus Research

6 months ago

XNCR: What does Argus have to say about XNCR?

Argus Research

6 months ago

XNCR: Raising target price to $21.00

Argus Research

6 months ago

XNCR: What does Argus have to say about XNCR?

Xencor (NASDAQ:XNCR) shareholders have endured a 52% loss from investing in the stock five years ago

Simply Wall St.

7 months ago

Xencor (NASDAQ:XNCR) shareholders have endured a 52% loss from investing in the stock five years ago

MT Newswires

7 months ago

Raymond James Adjusts Price Target on Xencor to $40 From $58, Maintains Strong Buy Rating

MT Newswires

7 months ago

BMO Capital Adjusts Xencor's Price Target to $32 From $34, Keeps Outperform Rating

MT Newswires

7 months ago

RBC Trims Price Target on Xencor to $31 From $32, Maintains Outperform, Speculative Risk Rating

MT Newswires

7 months ago

Wedbush Cuts Price Target on Xencor to $34 From $36, Maintains Outperform Rating

MT Newswires

7 months ago

Xencor to Regain Exclusive Global Rights to CD20 x CD3 Bispecific T-Cell Engager

Xencor Regains CD20 x CD3 Bispecific T-Cell Engager

Business Wire

7 months ago

Xencor Regains CD20 x CD3 Bispecific T-Cell Engager

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

GOBankingRates

7 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

Business Insider

7 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women

Insider Monkey

7 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Reuters

7 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Insider Monkey

7 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow

AFP

7 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

Investor's Business Daily

7 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

The Wall Street Journal

7 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Xencor First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

8 months ago

Xencor First Quarter 2024 Earnings: Misses Expectations

GuruFocus.com

8 months ago

Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates

MT Newswires

8 months ago

Wedbush Adjusts Xencor's Price Target to $36 From $34, Keeps Outperform Rating

Associated Press Finance

8 months ago

Xencor: Q1 Earnings Snapshot

Xencor Reports First Quarter 2024 Financial Results

Business Wire

8 months ago

Xencor Reports First Quarter 2024 Financial Results

Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

9 months ago

Xencor (XNCR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares

GuruFocus.com

9 months ago

Insider Sale at Xencor Inc (XNCR): EVP, Chief Development Officer Nancy Valente Sells Shares

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?

Zacks

9 months ago

Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?

Argus Research

9 months ago

XNCR: Lowering target price to $19.00

Xencor Appoints Bart Cornelissen as Chief Financial Officer

Business Wire

9 months ago

Xencor Appoints Bart Cornelissen as Chief Financial Officer

Insider Sell: SR. VICE PRESIDENT & CFO John Kuch Sells 4,474 Shares of Xencor Inc (XNCR)

GuruFocus.com

10 months ago

Insider Sell: SR. VICE PRESIDENT & CFO John Kuch Sells 4,474 Shares of Xencor Inc (XNCR)

Insider Sell: President & CEO Bassil Dahiyat Sells 12,528 Shares of Xencor Inc (XNCR)

GuruFocus.com

a year ago

Insider Sell: President & CEO Bassil Dahiyat Sells 12,528 Shares of Xencor Inc (XNCR)

Xencor Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

a year ago

Xencor Full Year 2023 Earnings: Misses Expectations

Xencor to Present at Upcoming Investor Conferences

Business Wire

a year ago

Xencor to Present at Upcoming Investor Conferences

Thomson Reuters StreetEvents

a year ago

Q4 2023 Xencor Inc Earnings Call

Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript

Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates

Zacks

a year ago

Xencor (XNCR) Reports Q4 Loss, Misses Revenue Estimates

Xencor Inc (XNCR) Reports Mixed Financial Results for Q4 and Full Year 2023

GuruFocus.com

a year ago

Xencor Inc (XNCR) Reports Mixed Financial Results for Q4 and Full Year 2023

Associated Press Finance

a year ago

Xencor: Q4 Earnings Snapshot

Xencor Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Xencor Reports Fourth Quarter and Full Year 2023 Financial Results

Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update

Business Wire

a year ago

Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update

Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?

Zacks

a year ago

Xencor (XNCR) Surges 13.4%: Is This an Indication of Further Gains?

Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Zacks

a year ago

Xencor (XNCR) Earnings Expected to Grow: What to Know Ahead of Q4 Release

Factors to Note Ahead of Lumen's (LUMN) Q4 Earnings Release

Zacks

a year ago

Factors to Note Ahead of Lumen's (LUMN) Q4 Earnings Release

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share

GlobeNewswire

a year ago

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.16 Per Share

Tilray Beers: A Lock for the Big Game

GlobeNewswire

a year ago

Tilray Beers: A Lock for the Big Game

Gas prices in 'glacial grind higher' for now — here's why

Yahoo Finance

a year ago

Gas prices in 'glacial grind higher' for now — here's why

Butterfield to Announce Fourth Quarter and Full Year 2023 Financial Results on February 12, 2024 and Host Earnings Conference Call on February 13, 2024

Business Wire

a year ago

Butterfield to Announce Fourth Quarter and Full Year 2023 Financial Results on February 12, 2024 and Host Earnings Conference Call on February 13, 2024

First Financial Bancorp. (NASDAQ:FFBC) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

First Financial Bancorp. (NASDAQ:FFBC) Q4 2023 Earnings Call Transcript

Share on Social Networks: